Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT04373460
Eligibility Criteria:
Inclusion Criteria:
* ≥ 18 years of age
* Competent and capable to provide informed consent
* • Positive molecular test for presence of SARS-CoV-2 in fluid collected by saliva for antigen, oropharyngeal or nasopharyngeal swab
* Experiencing any symptoms of COVID-19 including but not limited to fever(T\> 100.5º F), cough, or other COVID associated symptoms like anosmia
* ≤ 8 days since the first symptoms of COVID-19
* ≤ 8 days since first positive SARS-CoV-2 RNA test
* Able and willing to comply with protocol requirements listed in the informed consent
Exclusion Criteria:
* Hospitalized or expected to be hospitalized within 24 hours of enrollment
* Psychiatric or cognitive illness or recreational drug/alcohol use that in the opinion of the principal investigator, would affect subject safety and/or compliance
* History of prior reactions to transfusion blood products
* Inability to complete therapy with the study product within 24 hours after enrollment
* Receiving any treatment drug for COVID-19 within 14 days prior to screening evaluation (monoclonal antibodies, compassionate use or study trial related). Steroid treatment at any time does not affect study eligibility
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04373460
Study Brief:
Protocol Section:
NCT04373460